Januvia, Onglyza and Tradjenta Dangers
According to a new study published in the peer-reviewed medical journal, The BMJ, the diabetes drugs Januvia, Onglyza and Tradjenta may increase the risk of…Read more
Saxenda Cancer Dangers
Our firm is investigating cases involving individuals who have taken the weight-loss drug Saxenda and subsequently been diagnosed with pancreatic cancer. The U.S. Food &…Read more
Uloric Heart Attacks & Strokes
UPDATE: (June 2018) - Consumer advocacy group Public Citizen has called on the FDA to recall the drug Uloric. "There is 'overwhelming evidence that the…Read more
Actemra & Heart Attacks
UPDATE: (July 2018) - The U.S Food & Drug Administration is evaluating whether they need to take action regarding Actemra due to adverse event reports…Read more
Lyrica Birth Defects
Lyrica (pregabalin) is an anti-epileptic medication, also called an anticonvulsant. It is used to treat pain caused by nerve damage due to diabetes or shingles…Read more
Onglyza, Nesina, Kombiglyze & Heart Failure
An FDA safety review has determined the type 2 diabetes medicines Onglyza, Nesina, and Kombiglyze may increase the risk of heart failure, particularly in patients…Read more
Farxiga & Jardiance
Farxiga and Jardiance are part of a new class of diabetes drugs that also includes Invokana. These diabetes drugs, called SGLT2 Inhibitors, are already causing…Read more
Invokana
UPDATE: (Aug. 2018) - Yet another medical study has found that SGLT-2 Inhibitors, like Invokana, significantly increase the risk a user will have to undergo…Read more